Business Context and Reporting Period
This Form 8-K Current Report is filed by Paysign, Inc. on September 15, 2025. The filing serves as a Regulation FD disclosure regarding the status of previously reported stockholder derivative actions and the scheduling of a final approval hearing for a proposed settlement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal proceedings and corporate governance matters rather than financial performance metrics.
Material Changes and Legal Proceedings
- Settlement Agreement: On November 25, 2024, Paysign entered into a Stipulation and Agreement of Settlement to resolve four stockholder derivative actions (Toczek, Gray, Blanchette, and Jeewa) pending in the U.S. District Court for the District of Nevada.
- Allegations: The derivative actions alleged violations of Sections 10(b) and 14(a) of the Exchange Act, breaches of fiduciary duty, unjust enrichment, and waste.
- Settlement Terms: Upon final court approval, the settlement will release all claims, dismiss the actions with prejudice, and require the Company to adopt specific corporate governance reforms. The settlement is not an admission of fault.
- Procedural Status: A Motion for Preliminary Approval was filed on December 6, 2024. The Court has scheduled a final approval hearing for November 14, 2025, at 1:00 p.m.
Outlook, Risks, and Management Commentary
Management believes that resolving these claims is in the best interest of the Company and its stockholders, citing the costs and risks inherent in continued litigation. The primary risk identified is the uncertainty of the Court's final approval of the settlement terms on November 14, 2025. No financial guidance or operational outlook is provided in this filing.
Investor Verification Checklist
- Verify the outcome of the final approval hearing scheduled for November 14, 2025.
- Review the specific corporate governance reforms mandated by the Stipulation (Exhibit 99.2).
- Confirm whether the settlement includes any monetary payment to the Company or plaintiffs, as specific financial terms are not detailed in the summary text.
- Monitor for any objections filed by stockholders prior to the final hearing.